CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 46.11
  • -0.51-1.09%
Market Closed Dec 26 15:00 CST
294.14BMarket Cap53.99P/E (TTM)

About Jiangsu Hengrui Pharmaceuticals Company

The company was founded in 1970 and listed on the Shanghai Stock Exchange in 2000. It is an innovative international pharmaceutical enterprise focusing on R&D, production and promotion of high-quality drugs. It focuses on research and development of new drugs in the fields of anti-tumor, metabolic diseases, autoimmune diseases, respiratory diseases, neurological diseases, etc., and is one of the leading pharmaceutical companies with the most innovative ability in China. The company's main business involves R&D, production and sales of pharmaceuticals. Main products: Thiopefigastine injections, pyrrolitinib maleate tablets, carrerizumab for injection, haecripopa ethanolamine tablets, iodiphenol injections, butorphinol tartrate injections. Corporate honors: “Environmental Exemplary Enterprise” and “Leading Green Development Enterprise” in Jiangsu Province, won the Lianyungang Economic and Technological Development Zone Enterprise “Environmental Protection Quality Award” in 2023, won the honorary title of “First Batch of Sterile Drug Quality Assurance Enterprises” issued by the China Pharmaceutical Quality Management Association, and the honorary title of “Jiangsu Pharmaceutical Industry Excellent Quality Management Enterprise” issued by the Jiangsu Pharmaceutical Quality Management Association; the company's “Young Eagle QC Group” and “Yuanzhi QC Group” were rated as excellent exchange groups for Jiangsu Pharmaceutical Industry Quality Management (QC).

Company Profile

Short Name-A恒瑞医药
Symbol-A600276
Company NameJIANGSU HENGRUI MEDICINE CO.LTD
Listing DateOct 18, 2000
Issue Price11.98
Shares Offered40.00M share(s)
FoundedApr 28, 1997
Listed ExchangeSH Stock Exchange
Legal Representativepiaoyang sun
General Managerhongbin dai
Secretaryxiaohan liu
Accounting FirmErnst & Young Huaming Certified Public Accountants (Special General Partnership)
Securities Representativefei tian
Legal CounselGuo Hao Law Firm (Nanjing)
Employees7146
Phone021-61053323
Office AddressNo. 7 Kunlunshan Road, Lianyungang Economic and Technological Development Zone, Jiangsu
Zip Code222000
Registered AddressNo. 38 Huanghe Road, Lianyungang Economic and Technological Development Zone, Jiangsu
Fax021-61063801
Emailir@hengrui.com
Websitehttps://www.hengrui.com
Business License320700000006736
BusinessTablets (including antineoplastic agents), oral solutions, suspensions, sterile raw materials (antineoplastic agents), raw materials (including antineoplastic drugs), psychotropic drugs, softgels (including antineoplastic drugs), freeze-dried powder injections (including antineoplastic drugs, cephalosporins), inhaled powders, oral suspensions, oral emulsions, high-volume injections (containing multi-layer co-extruded infusion bags, containing anti-tumor drugs), small-volume injections (containing non-antitumor drugs) Sterilized), bioengineered products (polyethylene glycol recombinant human granulocyte stimulating factor injection), hard capsules (including antineoplastic agents), granules Manufacture of agents (antineoplastic drugs), powders, membranes, gels, and creams; pre-treatment and extraction of traditional Chinese medicines; R&D, manufacture and sale of medical devices; sales of general chemical products; self-employment and agency of import and export business of various commodities and technologies, with the exception of goods and technologies operated by companies restricted by the state or prohibited from being imported and exported.

Company Executives

  • Name
  • Position
  • Salary
  • piaoyang sun
  • Chairman, Directors, Chairman of the Strategy Committee, Nomination Committee Members
  • 1.62M
  • jieping sun
  • Directors, Deputy General Manager, Audit Committee Member
  • 2.35M
  • lianshan zhang
  • Directors, Deputy General Manager, Strategy Committee Member
  • 3.34M
  • hongbin dai
  • Directors, General Manager, Member of the Remuneration and Assessment Committee, Strategy Committee Member
  • 3.82M
  • ningjun jiang
  • Directors, Deputy General Manager, Authorized Representative, Strategy Committee Member
  • 2.34M
  • congzhao guo
  • Directors, Strategy Committee Member
  • --
  • jinyun sun
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
  • 100.00K
  • qingsheng ceng
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 100.00K
  • jiahong dong
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member, Audit Committee Member
  • --
  • xiaohan liu
  • Board Secretary, Joint Company Secretary
  • 799.10K
  • fei tian
  • Securities Affairs Representative
  • --
  • kaihong yuan
  • Chairman of the Supervisory Board, Auditors
  • 1.90M
  • guoqiang xiong
  • Auditors
  • --
  • yun lu
  • Deputy General Manager
  • --
  • cheng liao
  • Deputy General Manager
  • 2.29M
  • jinchun yan
  • Deputy General Manager
  • --
  • yan zhang
  • Deputy General Manager
  • 1.09M
  • xuejian xu
  • Deputy General Manager
  • --
  • yaping shen
  • Deputy General Manager
  • 2.05M
  • quanren wang
  • Deputy General Manager
  • 2.35M
  • feng he
  • Deputy General Manager
  • 2.48M
  • jianjun liu
  • Chief Financial Officer
  • 2.16M
  • yu xu
  • Employee Supervisors
  • 370.60K
  • yingxian liang
  • Authorized Representative, Joint Company Secretary
  • --
Heat List
CN
Overall
Symbol
Price
% Chg

No Data